Is Reducing Ovarian Volume in Polycystic Ovarian Syndrome Patients after Administration of Metformin Associated with Improving Cardiovascular Risk Factors?

Is Reducing Ovarian Volume in Polycystic Ovarian Syndrome Patients after Administration of Metformin Associated with Improving Cardiovascular Risk Factors?

Background Women with polycystic ovary syndrome (PCOS) are at increased risk for cardiovascular (CV) and metabolic disorders. There is a close relationship between elevated androgen plasma levels and the ultrasound findings of stromal hypertrophy. In randomized trials, the administration...

Full description

Bibliographic Details
Main Authors: Mohsen Gharakhani, Nosrat Neghab, Marzie Farimani
Format: Article
Language:English
Published: Royan Institute (ACECR), Tehran 2011-07-01
Series:International Journal of Fertility and Sterility
Subjects:
polycystic ovarian syndrome
metformin
metabolic syndrome
Online Access:http://www.ijfs.ir/article_45089_96cf04579e52c1138bc62e2f30393555.pdf

Similar Items

Similar Items